StockData
Can-Fite BioPharma Ltd. logo

Can-Fite BioPharma Ltd. (CANF) stock

CANFNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 1/30
$1.56+0.14 (+9.86%)

Close on Nov 16, 2026Market cap $2.04MP/E –Yield –

Can-Fite BioPharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Can-Fite BioPharma's price to sales ratio was 8.2× on Nov 11, 2026, against 6.9× a year earlier. Over the last 5 years it ranged from 3.9× to 42.1×, with a median of 13.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20268.2×+4.3
2025Dec 31, 20253.9×−8.3
2024Dec 31, 202412.2×+1.1
2023Dec 29, 202311.1×−8.5
2022Dec 30, 202219.5×−9.5
2021Dec 31, 202129.1×+17.1
2020Dec 31, 202012.0×+10.9
2019Dec 31, 20191.1×−24.8
2018Dec 31, 201826.0×−98.2
2017Dec 29, 2017124.2×+124.0
2016Dec 30, 20160.2×–

More Can-Fite BioPharma figures

See a number that looks wrong?